Strata Critical Medical: trust proposes $517K sale
The trust's notice also lists a 200,000-share acquisition connected with the August 29, 2025 merger with Blade Air Mobility, Inc.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Strata Critical Medical, Inc. (SRTA) lists a proposed sale of 100,000 Class A shares for the account of The Eric L. Affeldt Living Trust DTD 2/14/2005, with an aggregate market value of $517,000. UBS Financial Services Inc. is named in the notice, and the listed sale date is October 2, 2026. Eric L. Affeldt is identified as a trustee of the trust and a former board member of Strata Critical Medical. The notice also lists a 200,000-share acquisition connected with the August 29, 2025 merger with Blade Air Mobility, Inc., and reports 10,000 shares sold on August 26, 2026, with a reported value of $61,262.
Key Figures
Key Terms
Rule 144 regulatory
attorney-in-fact technical
person for whose account the securities are to be sold regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.